摘要
目的:探讨阿尔茨海默病中转化生长因子β1(TGF-β1)测定在诊治中的临床价值。方法:酶联免疫吸附分析法(ELISA)测定66例阿尔茨海默病患者和143例正常人血清TGF-β1含量,两者加以比较。结果:阿尔茨海默病组TGF-β1含量明显低于正常组,两组间存在显著性差异(P<0.05)。结论:TGF-β1参与阿尔茨海默病的发生。
Objective:T o study the effects of transforming growth factor-β1(TGF-β1) in Alzheimer’ s Disease(AD).Methods:There were 66 AD patients whose serum concentration of TGF-β1 was tested and compared with that of 143 normal persons.Results:The serum concentration of TGF-β1 in the AD patients(73.45±52.64) ng/ml was lower than the normal persons’(94.62ng/ ml ± 43.74ngΠ ml)(P〈0.05) 1There was significant differences between the two groups.Conclusions: TGF-β1 is possibly concerned with the occurrence and progress of Alzheimer’s disease.
出处
《中国民康医学》
2011年第3期268-269,共2页
Medical Journal of Chinese People’s Health
基金
广州市卫生局科研立项项目(2009-YB-240)
关键词
阿尔茨海默病
转化生长因子
血清
Mzheimer's Disease
Transforming growth factor
Serum